[3dem] Cryo-ET in Industry - Webinar by Clovertex

[Mazdak Radjainia]

Dear 3DEM and CCP-EM Community,

We’re pleased to invite you to the second session in our Clovertex Webinar
Series: *Cryo-Electron Tomography in Industry*
<https://urldefense.com/v3/__https://clovertex.com/cryo-electron-tomography-webinar/?utm_source=cryoduck&utm_medium=email&utm_campaign=tomography-webinar-2025-07__;!!Mih3wA!FbUTuHpLuQku1BwRqZkDqESGxVp_XwpiH96Q0mKELYv7dX9U6GSdql_Vh9bZAWDzSCMd3oYU9XEOAlz1NhM$ >
.

In our previous webinar, *Cryo-EM Processing in Industry* (watch it here
<https://urldefense.com/v3/__https://clovertex.com/cryo-em-processing-in-industry/__;!!Mih3wA!FbUTuHpLuQku1BwRqZkDqESGxVp_XwpiH96Q0mKELYv7dX9U6GSdql_Vh9bZAWDzSCMd3oYU9XEOTcClOSM$ >), one of the most
persistent questions from attendees centered on the demand for tomography
processing skills in industry. The sobering response was that,
realistically, tomography currently plays only a marginal role in most
industrial settings — a sharp contrast to academic excitement around
cryo-ET. This disconnect was surprising to many and underscored the need
for a more open and nuanced conversation within the community.

Tomography offers unique strengths, particularly in capturing structural
detail within native cellular environments. However, there are significant
practical and biological limitations that currently hinder its broader
adoption compared to single particle analysis and other established
structural approaches. At the same time, cryo-ET could create new
opportunities for microscopists to contribute to discovery in ways not yet
fully explored by industry.

This webinar aims to explore both sides of that conversation: how
scientists in academia or those considering a move to industry can better
understand the practical needs and expectations of industrial research, and
how those already working in industry might re-evaluate the potential
contributions tomography can make to drug discovery.

To help us navigate this discussion, we’re fortunate to be joined by two
experts who bring both depth and firsthand industry perspective to the
topic. *Maryam Khoshouei* (Novartis) and *Dimitry Tegunov* (Genentech) have
both contributed to method development for cryo-ET in academia and now work
in industrial settings. Their combined experience at the interface of
technology development and applied research makes them uniquely suited to
speak to the current realities and future potential of tomography in drug
discovery.

*Webinar Details*
*Title:* *Cryo-ET in Industry*
*Date & Time:* July 31 at 11:00 AM EST (8:00 AM PST | 5:00 PM CET)
*Format:* Roundtable discussion with interactive Q&A
*Registration:* Register here
<https://urldefense.com/v3/__https://clovertex.com/cryo-electron-tomography-webinar/?utm_source=cryoduck&utm_medium=email&utm_campaign=tomography-webinar-2025-07__;!!Mih3wA!FbUTuHpLuQku1BwRqZkDqESGxVp_XwpiH96Q0mKELYv7dX9U6GSdql_Vh9bZAWDzSCMd3oYU9XEOAlz1NhM$ >

As with our first session, this will be a live and interactive event.
Attendees are encouraged to bring questions and engage directly with our
panelists throughout the session.

*About the Panelists*

*Dimitry Tegunov*
*Principal Scientist & Group Leader, Genentech*
LinkedIn

Dimitry Tegunov, Ph.D., is Principal Scientist and Group Leader at
Genentech, where he develops advanced computational methods for cryo-EM and
in situ structural biology. With a background in biochemistry, biophysics,
and computer science, he has contributed to key structural studies of
macromolecular complexes and viral polymerases, including SARS-CoV-2.
Previously at the Max Planck Institute, Dimitry combines algorithm design
with molecular biology to resolve the structure and dynamics of
macromolecules at near-atomic resolution.

*Maryam Khoshouei*
*Principal Scientist, Novartis*
LinkedIn

Maryam Khoshouei, Ph.D., is a Principal Scientist at the Novartis
Institutes for BioMedical Research, where she uses advanced cryo-EM to
accelerate drug discovery. She earned her Ph.D. at the Max Planck Institute
of Biochemistry and holds degrees in applied physics and nanotechnology
from Chalmers University. Maryam helped develop phase contrast methods
later commercialized by Thermo Fisher. Her work bridges physics and life
sciences to translate structural insights into biomedical breakthroughs.

*About Clovertex*
Clovertex specializes in cryo-EM cloud infrastructure for biotech and
pharma, delivering tailored, scalable, and compliant solutions that evolve
with customer needs. As an AWS Life Sciences Competency Partner, Clovertex
is recognized for its expertise in Research IT, particularly its impact on
cryo-EM for drug discovery. Clovertex automates hardware, software, and
data management within a customer’s own cloud account (e.g., AWS) while
ensuring compliance with corporate IT policies. Continuously maintained and
optimized, it’s the smart way to run cryo-EM on AWS and the cloud—so
scientists can focus on science, not IT.

We hope you’ll join us for what we expect will be a thoughtful and timely
conversation.

https://urldefense.com/v3/__https://clovertex.com/cryo-electron-tomography-webinar/?utm_source=cryoduck&utm_medium=email&utm_campaign=tomography-webinar-2025-07__;!!Mih3wA!FbUTuHpLuQku1BwRqZkDqESGxVp_XwpiH96Q0mKELYv7dX9U6GSdql_Vh9bZAWDzSCMd3oYU9XEOAlz1NhM$ 
Kind regards,

*Mazdak* | cryoDuck B.V.
Home <https://urldefense.com/v3/__http://cryoduck.com__;!!Mih3wA!FbUTuHpLuQku1BwRqZkDqESGxVp_XwpiH96Q0mKELYv7dX9U6GSdql_Vh9bZAWDzSCMd3oYU9XEOX_bwm_E$ > / Newsletter <https://urldefense.com/v3/__http://cryoduck.com/newsletter/__;!!Mih3wA!FbUTuHpLuQku1BwRqZkDqESGxVp_XwpiH96Q0mKELYv7dX9U6GSdql_Vh9bZAWDzSCMd3oYU9XEOBeBzSe0$ > /
Blog <https://urldefense.com/v3/__http://cryoduck.com/blog/__;!!Mih3wA!FbUTuHpLuQku1BwRqZkDqESGxVp_XwpiH96Q0mKELYv7dX9U6GSdql_Vh9bZAWDzSCMd3oYU9XEOmmu-m5c$ >
+31610585016
5615EC 86 - Netherlands
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.ncmir.ucsd.edu/pipermail/3dem/attachments/20250721/2789e5a3/attachment.html>